Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study (2022)
- Authors:
- USP affiliated authors: BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM ; KALLAS, ESPER GEORGES - FM ; SILVA, VIVIAN HELENA IIDA AVELINO DA - FM
- Unidade: FM
- DOI: 10.1016/S2352-3018(22)00033-9
- Subjects: HIV; COVID-19; VACINAS VIRAIS
- Agências de fomento:
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (NEA)
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (SGP)
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CAS)
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (EB)
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (TP)
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (EB)
- B3-Bolsa de Valores do Brasil
- NIH
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Lancet hiv
- ISSN: 2352-3018
- Volume/Número/Paginação/Ano: v. 9, n. 5, p. E323-E331, 2022
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
NETTO, Lucas C et al. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study. Lancet hiv, v. 9, n. 5, p. E323-E331, 2022Tradução . . Disponível em: https://doi.org/10.1016/S2352-3018(22)00033-9. Acesso em: 06 maio 2024. -
APA
Netto, L. C., Ibrahim, K. Y., Picone, C. M., Alves, A. P. P. S., Aniceto, E. V., Santiago, M. R., et al. (2022). Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study. Lancet hiv, 9( 5), E323-E331. doi:10.1016/S2352-3018(22)00033-9 -
NLM
Netto LC, Ibrahim KY, Picone CM, Alves APPS, Aniceto EV, Santiago MR, Parmejani PSS, Bonfa ESD de O, Kallas EG, Silva VHIA da. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study [Internet]. Lancet hiv. 2022 ; 9( 5): E323-E331.[citado 2024 maio 06 ] Available from: https://doi.org/10.1016/S2352-3018(22)00033-9 -
Vancouver
Netto LC, Ibrahim KY, Picone CM, Alves APPS, Aniceto EV, Santiago MR, Parmejani PSS, Bonfa ESD de O, Kallas EG, Silva VHIA da. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study [Internet]. Lancet hiv. 2022 ; 9( 5): E323-E331.[citado 2024 maio 06 ] Available from: https://doi.org/10.1016/S2352-3018(22)00033-9 - Circulating Follicular Helper–Like T Cells in Systemic Lupus Erythematosus: Association With Disease Activity
- Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort
- Predictors of mortality in patients with yellow fever: an observational cohort study
- Access and adherence to isoniazid preventive therapy and occurrence of active TB in a cohort of people living with HIV: a retrospective cohort study in Sao Paulo, Brazil
- Safer sex in older age. [Editorial]: putting combination HIV prevention strategies into practice
- Impact of COVID-19 on income, prevention attitudes, and access to healthcare among male clients in a Sexually Transmitted Infections clinic
- Impact of antiretroviral regimen on viral suppression among pregnant women living with HIV in Brazil
- Predictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet survey
- Post-exposure prophylaxis following consented sexual exposure: impact of national recommendations on user profile, drug regimens and estimates of averted HIV infections
- Impact of coronavirus disease (COVID-19) on HIV testing and care provision across four continents
Informações sobre o DOI: 10.1016/S2352-3018(22)00033-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
